BRAF <sup>V600</sup> and ErbB inhibitors directly activate GCN2 in an off-target manner to limit cancer cell proliferationC. Ryland Ill, Sabrina L. Spencer|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 2